| SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe European heart journal 42 (25), 2439-2454, 2021 | 254 | 2021 |
| Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium FJ Brunner, C Waldeyer, F Ojeda, V Salomaa, F Kee, S Sans, B Thorand, ... The lancet 394 (10215), 2173-2183, 2019 | 254 | 2019 |
| Diagnosis of myocardial infarction using a high-sensitivity troponin I 1-hour algorithm JT Neumann, NA Sörensen, T Schwemer, F Ojeda, R Bourry, V Sciacca, ... JAMA cardiology 1 (4), 397-404, 2016 | 243 | 2016 |
| Lipoprotein (a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium C Waldeyer, N Makarova, T Zeller, RB Schnabel, FJ Brunner, ... European heart journal 38 (32), 2490-2498, 2017 | 206 | 2017 |
| Popeye domain containing proteins are essential for stress-mediated modulation of cardiac pacemaking in mice A Froese, SS Breher, C Waldeyer, RFR Schindler, VO Nikolaev, S Rinné, ... The Journal of clinical investigation 122 (3), 1119-1130, 2012 | 161 | 2012 |
| Venoarterial extracorporeal membrane oxygenation for cardiopulmonary support: insights from a German registry PM Becher, B Schrage, CR Sinning, B Schmack, N Fluschnik, M Schwarzl, ... Circulation 138 (20), 2298-2300, 2018 | 110 | 2018 |
| Relations between lipoprotein (a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic … S Zewinger, ME Kleber, V Tragante, RO McCubrey, AF Schmidt, K Direk, ... The lancet Diabetes & endocrinology 5 (7), 534-543, 2017 | 98 | 2017 |
| Inflammation and cardiovascular disease: the future N Arnold, K Lechner, C Waldeyer, MD Shapiro, W Koenig European Cardiology Review 16, 2021 | 70 | 2021 |
| Adverse outcome prediction of iron deficiency in patients with acute coronary syndrome T Zeller, C Waldeyer, F Ojeda, RB Schnabel, S Schäfer, A Altay, ... Biomolecules 8 (3), 60, 2018 | 63 | 2018 |
| Regional, age-dependent, and genotype-dependent differences in ventricular action potential duration and activation time in 410 Langendorff-perfused mouse hearts C Waldeyer, L Fabritz, L Fortmueller, J Gerss, D Damke, A Blana, ... Basic research in cardiology 104, 523-533, 2009 | 49 | 2009 |
| Contribution of cystatin C-and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the … D Rothenbacher, M Rehm, L Iacoviello, S Costanzo, H Tunstall-Pedoe, ... BMC medicine 18, 1-13, 2020 | 46 | 2020 |
| Adherence to Mediterranean diet, high-sensitive C-reactive protein, and severity of coronary artery disease: contemporary data from the INTERCATH cohort C Waldeyer, FJ Brunner, J Braetz, N Ruebsamen, BC Zyriax, C Blaum, ... Atherosclerosis 275, 256-261, 2018 | 46 | 2018 |
| Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population C Blaum, FJ Brunner, F Kröger, J Braetz, T Lorenz, A Goßling, F Ojeda, ... European journal of preventive cardiology 28 (2), 152-158, 2021 | 43 | 2021 |
| Risk prediction of in-hospital mortality in patients with venoarterial extracorporeal membrane oxygenation for cardiopulmonary support: The ECMO-ACCEPTS score PM Becher, R Twerenbold, B Schrage, B Schmack, CR Sinning, ... Journal of critical care 56, 100-105, 2020 | 32 | 2020 |
| Iron metabolism contributes to prognosis in coronary artery disease: prognostic value of the soluble transferrin receptor within the AtheroGene study H Weidmann, JH Bannasch, C Waldeyer, A Shrivastava, S Appelbaum, ... Journal of the American Heart Association 9 (9), e015480, 2020 | 31 | 2020 |
| Intravascular Lithotripsy for the Treatment of Calcium-Mediated Coronary In-Stent Restenoses. FJ Brunner, PM Becher, C Waldeyer, E Zengin-Sahm, RB Schnabel, ... The Journal of Invasive Cardiology 33 (1), E25-E31, 2021 | 22 | 2021 |
| Genome-wide association analysis for severity of coronary artery disease using the gensini scoring system T Zeller, M Seiffert, C Müller, M Scholz, A Schäffer, F Ojeda, H Drexel, ... Frontiers in cardiovascular medicine 4, 57, 2017 | 21 | 2017 |
| Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort C Blaum, FJ Brunner, A Goßling, F Kröger, B Bay, T Lorenz, A Graef, ... Clinical Therapeutics 43 (9), 1583-1600, 2021 | 20 | 2021 |
| Intrinsic iron release is associated with lower mortality in patients with stable coronary artery disease—first report on the prospective relevance of intrinsic iron release J Ruhe, C Waldeyer, F Ojeda, A Altay, RB Schnabel, S Schäfer, ... Biomolecules 8 (3), 72, 2018 | 20 | 2018 |
| Prognostic value of iron-homeostasis regulating peptide hepcidin in coronary heart disease—evidence from the large AtheroGene study T Zeller, A Altay, C Waldeyer, S Appelbaum, F Ojeda, J Ruhe, ... Biomolecules 8 (3), 43, 2018 | 20 | 2018 |
